Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Vericel Corp (VCEL)  
$42.55 0.82 (1.97%) as of 4:30 Mon 6/30


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 55,839,000
Market Cap: 2.38(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $37.92 - $61.8
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:

    NASDAQ COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  1139
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 94,825 155,676 418,389 773,623
Total Sell Value $3,921,467 $7,120,879 $19,841,755 $35,051,168
Total People Sold 3 9 11 11
Total Sell Transactions 6 18 44 82
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 444
  Page 1 of 18  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2025-06-02 4 AS $40.09 $400,900 D/D (10,000) 66,237 3%     
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2025-06-02 4 OE $18.00 $180,000 D/D 10,000 76,237     -
   Colangelo Dominick President and CEO   •       •      –    2025-05-15 4 AS $41.53 $584,036 D/D (14,063) 260,354 1%     
   Colangelo Dominick President and CEO   •       •      –    2025-05-15 4 OE $2.65 $37,267 D/D 14,063 274,417     -
   Colangelo Dominick President and CEO   •       •      –    2025-05-14 4 AS $42.25 $594,120 D/D (14,062) 260,354 -1%     
   Colangelo Dominick President and CEO   •       •      –    2025-05-14 4 OE $2.65 $37,264 D/D 14,062 274,416     -
   Mclaughlin Kevin F   •       •      –    2025-05-07 4 AS $39.98 $279,860 D/D (7,000) 15,100 3%     
   Mclaughlin Kevin F   •       •      –    2025-05-07 4 OE $2.76 $19,320 D/D 7,000 22,100     -
   Mclaughlin Kevin F   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 15,100     -
   Wright Lisa   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 12,651     -
   Wotton Paul K   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 30,602     -
   Hagen Heidi   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 31,850     -
   Rubino Alan L   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 45,994     -
   Zerbe Robert L Md   •       •      –    2025-04-30 4 OE $0.00 $0 D/D 3,200 29,795     -
   Colangelo Dominick President and CEO   •       •      –    2025-04-10 4 AS $41.89 $1,040,967 D/D (24,850) 260,354 -0%     
   Colangelo Dominick President and CEO   •       •      –    2025-04-10 4 OE $2.75 $68,338 D/D 24,850 285,204     -
   Colangelo Dominick President and CEO   •       •      –    2025-04-09 4 AS $41.11 $1,021,584 D/D (24,850) 260,354 -6%     
   Colangelo Dominick President and CEO   •       •      –    2025-04-09 4 OE $2.75 $68,338 D/D 24,850 285,204     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2025-03-03 4 AS $49.53 $495,300 D/D (10,000) 66,101 -16%     
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2025-03-03 4 OE $18.00 $180,000 D/D 10,000 76,101     -
   Hagen Heidi   •       •      –    2025-03-03 4 AS $49.53 $445,770 D/D (9,000) 28,650 -16%     
   Hagen Heidi   •       •      –    2025-03-03 4 OE $3.74 $33,660 D/D 9,000 37,650     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2025-03-03 4 AS $49.53 $445,770 D/D (9,000) 13,967 -16%     
   Halpin Michael Chief Operating Officer   •       •      –    2025-03-03 4 AS $49.52 $495,200 D/D (10,000) 15,539 -16%     
   Halpin Michael Chief Operating Officer   •       •      –    2025-03-03 4 OE $16.66 $166,600 D/D 10,000 25,359     -

  444 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 18
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed